ATF2 impairs glucocorticoid receptor-mediated transactivation in human CD8+ T cells.

Chronic inflammatory diseases often have residual CD8(+) T-cell infiltration despite treatment with systemic corticosteroids, which suggests divergent steroid responses between CD4(+) and CD8(+) cells. To examine steroid sensitivity, dexamethasone (DEX)-induced histone H4 lysine 5 (K5) acetylation and glucocorticoid receptor alpha (GCR alpha) translocation were evaluated. DEX treatment for 6 hours significantly induced histone H4 K5 acetylation in normal CD4(+) cells (P = .001) but not in CD8(+) cells. DEX responses were functionally impaired in CD8(+) compared with CD4(+) cells when using mitogen-activated protein kinase phosphatase (1 hour; P = .02) and interleukin 10 mRNA (24 hours; P = .004) induction as a readout of steroid-induced transactivation. Normal DEX-induced GCR alpha nuclear translocation and no significant difference in GCR alpha and GCR beta mRNA expression were observed in both T-cell types. In addition, no significant difference in SRC-1, p300, or TIP60 expression was found. However, activating transcription factor-2 (ATF2) expression was significantly lower in CD8(+) compared with CD4(+) cells (P = .009). Importantly, inhibition of ATF2 expression by small interfering RNA in CD4(+) cells resulted in inhibition of DEX-induced transactivation in CD4(+) cells. The data indicate refractory steroid-induced transactivation but similar steroid-induced transrepression of CD8(+) cells compared with CD4(+) cells caused by decreased levels of the histone acetyltransferase ATF2.

[1]  J. Cidlowski,et al.  Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  D. Leung,et al.  Divergent expression and function of glucocorticoid receptor β in human monocytes and T cells , 2006, Journal of leukocyte biology.

[3]  Takashi Nakamura,et al.  Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. , 2006, Endocrine journal.

[4]  Richard J Martin,et al.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. , 2006, American journal of respiratory and critical care medicine.

[5]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[6]  I. Adcock,et al.  Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.

[7]  D. Leung,et al.  Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. , 2006, Journal of leukocyte biology.

[8]  P. Moss,et al.  CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden. , 2005, Blood.

[9]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[10]  G. Chrousos,et al.  Intracellular Glucocorticoid Signaling: A Formerly Simple System Turns Stochastic , 2005, Science's STKE.

[11]  P. Sterk,et al.  Bronchial CD8 cell infiltrate and lung function decline in asthma. , 2005, American journal of respiratory and critical care medicine.

[12]  G. Chrousos,et al.  The Human Glucocorticoid Receptor (GR) Isoform β Differentially Suppresses GRα-Induced Transactivation Stimulated by Synthetic Glucocorticoids , 2005 .

[13]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[14]  I. Adcock,et al.  Histone acetylation and deacetylation: importance in inflammatory lung diseases , 2005, European Respiratory Journal.

[15]  G. Chrousos,et al.  The Human Glucocorticoid Receptor (hGR) β Isoform Suppresses the Transcriptional Activity of hGRα by Interfering with Formation of Active Coactivator Complexes , 2005 .

[16]  G. Chrousos,et al.  The human glucocorticoid receptor (GR) isoform {beta} differentially suppresses GR{alpha}-induced transactivation stimulated by synthetic glucocorticoids. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  G. Chrousos,et al.  The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. , 2005, Molecular endocrinology.

[18]  C. Peterson,et al.  Histones and histone modifications , 2004, Current Biology.

[19]  I. Adcock,et al.  Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. , 2004, The Journal of allergy and clinical immunology.

[20]  P. Barnes.  Corticosteroid resistance in airway disease. , 2004, Proceedings of the American Thoracic Society.

[21]  I. Adcock,et al.  Glucocorticoids: effects on gene transcription. , 2004, Proceedings of the American Thoracic Society.

[22]  M. Belvisi.  Regulation of inflammatory cell function by corticosteroids. , 2004, Proceedings of the American Thoracic Society.

[23]  K. Matsushima,et al.  Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis , 2003, Journal of the Neurological Sciences.

[24]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[25]  R. Ravid,et al.  Very low levels of the glucocorticoid receptor beta isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistry. , 2003, Brain research. Molecular brain research.

[26]  A. Clark,et al.  Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. , 2003, Current opinion in pharmacology.

[27]  J. Cidlowski,et al.  Molecular Origins for the Dominant Negative Function of Human Glucocorticoid Receptor Beta , 2003, Molecular and Cellular Biology.

[28]  Donald Y M Leung,et al.  Serine-Arginine-rich Protein p30 Directs Alternative Splicing of Glucocorticoid Receptor Pre-mRNA to Glucocorticoid Receptor β in Neutrophils* , 2003, Journal of Biological Chemistry.

[29]  J. Bloom,et al.  Update on glucocorticoid action and resistance. , 2003, The Journal of allergy and clinical immunology.

[30]  K. Kisich,et al.  A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1 , 2002, The Journal of Immunology.

[31]  G. Chrousos,et al.  Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. , 2002, American journal of respiratory cell and molecular biology.

[32]  H. Hashimoto,et al.  Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16. , 2002, Leukemia research.

[33]  O. Kassel,et al.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.

[34]  E. Sternberg.  Faculty Opinions recommendation of High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. , 2001 .

[35]  G. Chrousos,et al.  High Constitutive Glucocorticoid Receptor β in Human Neutrophils Enables Them to Reduce Their Spontaneous Rate of Cell Death in Response to Corticosteroids , 2001, The Journal of experimental medicine.

[36]  Y. Nakatani,et al.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation , 2000, Nature.

[37]  G. Chrousos,et al.  Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. , 2000, The Journal of allergy and clinical immunology.

[38]  J. Cidlowski,et al.  The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. , 1999, The Journal of biological chemistry.

[39]  Y. Takasaki,et al.  Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[40]  J. Cidlowski,et al.  Expression and Subcellular Distribution of the b-Isoform of the Human Glucocorticoid Receptor * , 1997 .

[41]  J. Cidlowski,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression and Subcellular Distribution of the �-Isoform , 2022 .

[42]  C. Allis,et al.  Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.

[43]  J. Cidlowski,et al.  The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. , 1996, The Journal of biological chemistry.

[44]  M. Eoli,et al.  High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. , 1994, The International journal of neuroscience.

[45]  R. Richards,et al.  Localization of phosphoprotein C23 to nucleolar structures and to the nucleolus organizer regions. , 1981, Experimental cell research.